BI 1569912 / Boehringer Ingelheim  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BI 1569912 / Boehringer Ingelheim
NCT06280235: A Study to Test Different Doses of BI 1569912 in People With Depression Who Take Anti-depressive Medicine

Recruiting
2
204
US
BI 1569912, Placebo
Boehringer Ingelheim
Depressive Disorder, Major
08/25
10/25

Download Options